Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for prevention of postoperative nausea, vomiting, and pain after breast reconstruction in post-bariatric patients
RBR-8y4bvbwRecruiting
- Sponsor
- Rafael Reis Fernandes
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of pregabalin in postoperative nausea and vomiting (PONV) and postoperative pain (2 arms), sponsored by Rafael Reis Fernandes. Primary endpoints: Postoperative nausea prevention and Postoperative vomiting prevention. Started Aug 2019; status: recruiting.
02
Drugs
pregabalin
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on RBR-8y4bvbw.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8y4bvbw.